Cardiac resynchronization therapy in congenital heart disease

Jan Janoušek1, Peter Kubuš2

  • 1Children's Heart Centre, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, V úvalu 84, 15006, Prague, Czech Republic. jan.janousek@fnmotol.cz.

Insights

Cardiac resynchronization therapy (CRT) shows promise for congenital heart disease (CHD) patients. Efficacy in CHD depends on systemic ventricle anatomy, with best outcomes in those with systemic left ventricles receiving CRT after conventional pacing.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Congenital Heart Disease

Background:

  • Cardiac resynchronization therapy (CRT) is effective for heart failure in adults with cardiomyopathy.
  • Limited data exists on CRT efficacy in patients with congenital heart disease (CHD).
  • CHD presents unique anatomical and functional challenges for CRT implantation.

Purpose of the Study:

  • To review the efficacy and implantation considerations of CRT in patients with CHD.
  • To highlight the importance of systemic ventricle anatomy in CRT outcomes for CHD.
  • To reference expert consensus guidelines on CRT in adult CHD.

Main Methods:

  • Review of existing literature on CRT in CHD.
  • Analysis of factors influencing CRT efficacy based on systemic ventricle anatomy.
  • Discussion of prevailing implantation techniques (thoracotomy, hybrid).

Main Results:

  • CRT efficacy in CHD appears dependent on systemic ventricle anatomy.
  • Best outcomes were observed in patients with a systemic left ventricle upgraded from conventional pacing.
  • Implantation techniques vary due to CHD structural heterogeneity.

Conclusions:

  • CRT may be a viable option for select CHD patients.
  • Systemic ventricle anatomy is a critical determinant of CRT success in CHD.
  • Further research is needed to optimize CRT in the diverse CHD population.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
728
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
643
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
531
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
751
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.5K